These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 34203295)
1. CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension. Pal-Ghosh R; Xue D; Warburton R; Hill N; Polgar P; Wilson JL Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203295 [TBL] [Abstract][Full Text] [Related]
2. Participation of PLK1 and FOXM1 in the hyperplastic proliferation of pulmonary artery smooth muscle cells in pulmonary arterial hypertension. Wilson JL; Wang L; Zhang Z; Hill NS; Polgar P PLoS One; 2019; 14(8):e0221728. PubMed ID: 31437238 [TBL] [Abstract][Full Text] [Related]
3. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension. Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405 [No Abstract] [Full Text] [Related]
5. Inhibition of YTHDF1 prevents hypoxia-induced pulmonary artery smooth muscle cell proliferation by regulating Foxm1 translation in an m6A-dependent manner. Kang T; Liu L; Tan F; Zhang D; Yu L; Jiang H; Qian W; Hua J; Zheng Z Exp Cell Res; 2023 Mar; 424(2):113505. PubMed ID: 36736607 [TBL] [Abstract][Full Text] [Related]
6. MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1. Zhao TF; Wang SY; Zou XZ; Zhao HD Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3495-3502. PubMed ID: 31081105 [TBL] [Abstract][Full Text] [Related]
7. Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension. Dai Z; Zhu MM; Peng Y; Jin H; Machireddy N; Qian Z; Zhang X; Zhao YY Am J Respir Crit Care Med; 2018 Sep; 198(6):788-802. PubMed ID: 29664678 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced pulmonary arterial smooth muscle cell proliferation is controlled by forkhead box M1. Raghavan A; Zhou G; Zhou Q; Ibe JC; Ramchandran R; Yang Q; Racherla H; Raychaudhuri P; Raj JU Am J Respir Cell Mol Biol; 2012 Apr; 46(4):431-6. PubMed ID: 22033266 [TBL] [Abstract][Full Text] [Related]
15. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling. He Y; Zuo C; Jia D; Bai P; Kong D; Chen D; Liu G; Li J; Wang Y; Chen G; Yan S; Xiao B; Zhang J; Piao L; Li Y; Deng Y; Li B; Roux PP; Andreasson KI; Breyer RM; Su Y; Wang J; Lyu A; Shen Y; Yu Y Am J Respir Crit Care Med; 2020 May; 201(10):1263-1276. PubMed ID: 31917615 [No Abstract] [Full Text] [Related]
16. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension. Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140 [TBL] [Abstract][Full Text] [Related]
17. Suppression of WEE1 and stimulation of CDC25A correlates with endothelin-dependent proliferation of rat aortic smooth muscle cells. Chen S; Gardner DG J Biol Chem; 2004 Apr; 279(14):13755-63. PubMed ID: 14742443 [TBL] [Abstract][Full Text] [Related]
18. Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression. Fu Z; Malureanu L; Huang J; Wang W; Li H; van Deursen JM; Tindall DJ; Chen J Nat Cell Biol; 2008 Sep; 10(9):1076-82. PubMed ID: 19160488 [TBL] [Abstract][Full Text] [Related]
19. Suppression of Vimentin Phosphorylation by the Avian Reovirus p17 through Inhibition of CDK1 and Plk1 Impacting the G2/M Phase of the Cell Cycle. Chiu HC; Huang WR; Liao TL; Wu HY; Munir M; Shih WL; Liu HJ PLoS One; 2016; 11(9):e0162356. PubMed ID: 27603133 [TBL] [Abstract][Full Text] [Related]
20. Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors. Mancini M; De Santis S; Monaldi C; Bavaro L; Martelli M; Castagnetti F; Gugliotta G; Rosti G; Santucci MA; Martinelli G; Cavo M; Soverini S J Exp Clin Cancer Res; 2019 May; 38(1):216. PubMed ID: 31122263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]